The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China
Open accessAbstract
Background The novel coronavirus disease 2019 (COVID-19) has become a global health emergency. The cumulative number of new confirmed cases and deaths are still increasing out of China. Independent predicted factors associated with fatal outcomes remain uncertain. Research Question The goal of the current study was to investigate the potential risk factors associated with fatal outcomes from COVID-19 through a multivariate Cox regression analysis and a nomogram model. Study Design and Methods A retrospective cohort of 1,590 hospitalized patients with COVID-19 throughout China was established. The prognostic effects of variables, including clinical features and laboratory findings, were analyzed by using Kaplan-Meier methods and a Cox proportional hazards model. A prognostic nomogram was formulated to predict the survival of patients with COVID-19. Results In this nationwide cohort, nonsurvivors included a higher incidence of elderly people and subjects with coexisting chronic illness, dyspnea, and laboratory abnormalities on admission compared with survivors. Multivariate Cox regression analysis showed that age ≥ 75 years (hazard ratio [HR], 7.86; 95% CI, 2.44-25.35), age between 65 and 74 years (HR, 3.43; 95% CI, 1.24-9.5), coronary heart disease (HR, 4.28; 95% CI, 1.14-16.13), cerebrovascular disease (HR, 3.1; 95% CI, 1.07-8.94), dyspnea (HR, 3.96; 95% CI, 1.42-11), procalcitonin level > 0.5 ng/mL (HR, 8.72; 95% CI, 3.42-22.28), and aspartate aminotransferase level > 40 U/L (HR, 2.2; 95% CI, 1.1-6.73) were independent risk factors associated with fatal outcome. A nomogram was established based on the results of multivariate analysis. The internal bootstrap resampling approach suggested the nomogram has sufficient discriminatory power with a C-index of 0.91 (95% CI, 0.85-0.97). The calibration plots also showed good consistency between the prediction and the observation. Interpretation The proposed nomogram accurately predicted clinical outcomes of patients with COVID-19 based on individual characteristics. Earlier identification, more intensive surveillance, and appropriate therapy should be considered in patients at high risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Self-citationA pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Self-citationChen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Self-citationWang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
Self-citationLa certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Self-citationYang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Cited by
Genomewide Association Study of Severe Covid-19 with Respiratory Failure
The Severe Covid-19 GWAS Group (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2020283 · Cited by 1,980
Acute kidney injury in patients hospitalized with COVID-19
Hirsch, J. S., Ng, J. H., Ross, D. W., Sharma, P., Shah, H. H., Barnett, R. L., Hazzan, A. D., Fishbane, S., Jhaveri, K. D., Abate, M., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.05.006 · Cited by 1,523
Exploring the effect of image enhancement techniques on COVID-19 detection using chest X-ray images
Rahman, T., Khandakar, A., Qiblawey, Y., Tahir, A., Kiranyaz, S., Abul Kashem, S. B., Islam, M. T., Al Maadeed, S., Zughaier, S. M., Khan, M. S., et al. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104319 · Cited by 1,147
Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis
Langford, B. J., So, M., Raybardhan, S., Leung, V., Soucy, J.-P. R., Westwood, D., Daneman, N., & MacFadden, D. R. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.12.018 · Cited by 876
Dessie, Z. G., & Zewotir, T. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06536-3 · Cited by 875
Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis
Francone, M., Iafrate, F., Masci, G. M., Coco, S., Cilia, F., Manganaro, L., Panebianco, V., Andreoli, C., Colaiacomo, M. C., Zingaropoli, M. A., et al. (2020) · European Radiology · doi:10.1007/s00330-020-07033-y · Cited by 806
Terpos, E., Engelhardt, M., Cook, G., Gay, F., Mateos, M.-V., Ntanasis-Stathopoulos, I., van de Donk, N. W. C. J., Avet-Loiseau, H., Hajek, R., Vangsted, A. J., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0876-z · Cited by 736
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
Dougan, M., Nirula, A., Azizad, M., Mocherla, B., Gottlieb, R. L., Chen, P., Hebert, C., Perry, R., Boscia, J., Heller, B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2102685 · Cited by 663
Izcovich, A., Ragusa, M. A., Tortosa, F., Lavena Marzio, M. A., Agnoletti, C., Bengolea, A., Ceirano, A., Espinosa, F., Saavedra, E., Sanguine, V., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0241955 · Cited by 660
Pijls, B. G., Jolani, S., Atherley, A., Derckx, R. T., Dijkstra, J. I. R., Franssen, G. H. L., Hendriks, S., Richters, A., Venemans-Jellema, A., Zalpuri, S., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044640 · Cited by 586
Acute kidney injury in critically ill patients with COVID-19
Gabarre, P., Dumas, G., Dupont, T., Darmon, M., Azoulay, E., & Zafrani, L. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06153-9 · Cited by 529
Bhaskar, S., Sinha, A., Banach, M., Mittoo, S., Weissert, R., Kass, J. S., Rajagopal, S., Pai, A. R., & Kutty, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01648 · Cited by 511
Risk factors for Covid-19 severity and fatality: a structured literature review
Wolff, D., Nee, S., Hickey, N. S., & Marschollek, M. (2021) · Infection · doi:10.1007/s15010-020-01509-1 · Cited by 511
Parohan, M., Yaghoubi, S., Seraji, A., Javanbakht, M. H., Sarraf, P., & Djalali, M. (2020) · The Aging Male · doi:10.1080/13685538.2020.1774748 · Cited by 469
The effect of smoking on COVID‐19 severity: A systematic review and meta‐analysis
Reddy, R. K., Charles, W. N., Sklavounos, A., Dutt, A., Seed, P. T., & Khajuria, A. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26389 · Cited by 458
Zhou, Z., Kang, H., Li, S., & Zhao, X. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09929-7 · Cited by 397
Self-citationA model of disparities: risk factors associated with COVID-19 infection
Rozenfeld, Y., Beam, J., Maier, H., Haggerson, W., Boudreau, K., Carlson, J., & Medows, R. (2020) · International Journal for Equity in Health · doi:10.1186/s12939-020-01242-z · Cited by 358
Klang, E., Kassim, G., Soffer, S., Freeman, R., Levin, M. A., & Reich, D. L. (2020) · Obesity · doi:10.1002/oby.22913 · Cited by 330
Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature
Bajgain, K. T., Badal, S., Bajgain, B. B., & Santana, M. J. (2021) · American Journal of Infection Control · doi:10.1016/j.ajic.2020.06.213 · Cited by 328
Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis
Noor, F. M., & Islam, M. M. (2020) · Journal of Community Health · doi:10.1007/s10900-020-00920-x · Cited by 301
Mantovani, A., Byrne, C. D., Zheng, M.-H., & Targher, G. (2020) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.05.014 · Cited by 271
Zhang, C. H., & Schwartz, G. G. (2020) · The Journal of Rural Health · doi:10.1111/jrh.12476 · Cited by 253
Aspergillosis Complicating Severe Coronavirus Disease
Marr, K. A., Platt, A., Tornheim, J. A., Zhang, S. X., Datta, K., Cardozo, C., & Garcia-Vidal, C. (2021) · Emerging Infectious Diseases · doi:10.3201/eid2701.202896 · Cited by 190
“Use of empirical antifungal drugs was frequent; in a large study evaluating risk factors for death, ≈50% of persons had secondary infections, and antifungal therapy was administered in 22% (21,22).”
BackgroundPediatric lung imaging features of COVID‐19: A systematic review and meta‐analysis
Nino, G., Zember, J., Sanchez‐Jacob, R., Gutierrez, M. J., Sharma, K., & Linguraru, M. G. (2021) · Pediatric Pulmonology · doi:10.1002/ppul.25070 · Cited by 65
Cao, L., & Liu, Q. (2022) · doi:10.1101/2022.08.22.22279022 · Cited by 49
Verbruggen, L. C., Wang, Y., Armenian, S. H., Ehrhardt, M. J., van der Pal, H. J. H., van Dalen, E. C., van As, J. W., Bardi, E., Baust, K., Berger, C., et al. (2020) · Pediatric Blood & Cancer · doi:10.1002/pbc.28702 · Cited by 31
Metadata
- Authors
- Chen, R., Liang, W., Jiang, M., Guan, W., Zhan, C., Wang, T., Tang, C., Sang, L., Liu, J., Ni, Z., Hu, Y., Liu, L., Shan, H., Lei, C., Peng, Y., Wei, L., Liu, Y., Hu, Y., Peng, P., Wang, J., Liu, J., Chen, Z., Li, G., Zheng, Z., Qiu, S., Luo, J., Ye, C., Zhu, S., Liu, X., Cheng, L., Ye, F., Zheng, J., Zhang, N., Li, Y., He, J., Li, S., & Zhong, N.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 158
- Issue
- 1
- Pages
- 97-105
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W3015671971
- Cited by
- 614
- References
- 24
- FWCI
- 17.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.